Viewing nowTopiramate 100 mg Tablet
Topiramate 100mg
Tablet · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.

MFDS item code 201801153 · Approved 2018.03.13
Treatment of epilepsy (including partial seizures); prevention of migraine
This medication is used to treat partial seizures and secondary generalized seizures in children aged 6 years and older and adults. It can also be administered as an adjunct therapy for various types of seizures that are not controlled by existing treatments, such as seizures related to Lennox-Gastaut syndrome and primary generalized tonic-clonic seizures. Additionally, it is effective in preventing migraines. Thus, this drug is used to treat and prevent various types of epilepsy seizures and migraines.
It is preferable to start this medicine at a low dose and increase it to the effective dose. Monitoring blood concentrations is not necessary to optimize treatment with this medicine. The recommended doses of this medicine apply to all adults and pediatric patients, including older adults, provided they do not have renal disease. This medicine may be taken with or without food. Tablets should be swallowed whole and not crushed. 1. Epilepsy 1) Monotherapy: When discontinuing other concomitant antiepileptic drugs to administer topiramate as monotherapy, consider the potential effects on seizure control. Unless other antiepileptic drugs must be discontinued immediately for safety reasons, gradually reduce and discontinue the other antiepileptic drugs by approximately 1/3 at 2-week intervals (see “5. General Precautions” under Precautions for Use). When enzyme-inducing drugs are discontinued, topiramate concentrations may increase. If a clinically significant increase in topiramate concentration occurs, the dose of this medicine may need to be reduced. Adults (17 years and older) : During the first week, start with 25㎎ in the evening. Thereafter, increase the dose by 25 or 50㎎ per day at 1-2-week intervals and administer in 2 divided doses. If the patient has difficulty tolerating this rate of dose increase, extend the intervals between increases. The dose and rate of increase should be determined according to clinical response. The recommended dose for monotherapy in adults is 100~200mg per day. The maximum recommended dose is 500㎎ per day. Some patients with recurrent epilepsy have tolerated topiramate monotherapy at doses of up to 1,000㎎ per day. 2) Adjunctive therapy Adults (17 years and older) The minimum effective dose is 200mg per day, and the usual dose is 200-400mg per day in 2 divided doses. Depending on the patient, the dose may be increased to the maximum recommended dose of 800mg per day. During the first week, start treatment with 25-50mg in the evening; starting at a lower dose is also possible. Thereafter, increase the dose by 25-50mg at 1-2-week intervals and administer in 2 divided doses. If the patient has difficulty tolerating the increased dose, smaller increments may be used or the intervals between increases may be extended. The dose should be determined according to clinical effect. 2. Prevention of migraine Adults: During the first week, start this medicine at 25mg in the evening. Thereafter, increase the dose by 25mg/day at 1-week intervals. If the patient has difficulty tolerating these increases, extend the intervals between increases. The recommended dose is 100mg per day, administered in 2 divided doses. Some patients may respond to a dose of 50mg per day. Doses of up to 200mg per day may be administered, and the dose and rate of increase should be determined according to clinical response. 3. Patients with renal impairment - For patients with moderate or severe renal impairment (CLcr < 70 mL/min/1.73 m2), it is recommended that the initial and maintenance doses be reduced to approximately 1/2. - Patients on hemodialysis: Because this medicine is removed from plasma by hemodialysis, increase the dose of this medicine by approximately 1/2 on dialysis days. Increase the dose taking into account the duration of dialysis, the clearance of the dialysis apparatus, and the patient's renal clearance, and administer divided doses at the start and end of hemodialysis. 4. Patients with hepatic impairment Use this medicine with caution in patients with hepatic impairment, as its clearance may be reduced.
Pediatric patients (6-16 years): During the first week, start with 0.5-1㎎/㎏ in the evening. Thereafter, increase the dose by 0.5-1㎎/㎏ per day at 1-2-week intervals and administer in 2 divided doses. If the patient has difficulty tolerating dose increases, reduce the increments or extend the intervals between increases. The dose and rate of increase should be determined according to clinical response. The recommended dose for monotherapy in pediatric patients is 3-6mg/kg per day. Doses of up to 500㎎ per day have been used in pediatric patients diagnosed with partial-onset seizures. Pediatric patients (2-16 years): The recommended daily dose is approximately 5-9mg/kg, administered in 2 divided doses. During the first week, administer 25mg (or less, based on 1-3mg/kg per day) in the evening. Thereafter, increase the dose by 1-3mg/kg per day at 1-2-week intervals until an appropriate clinical effect is achieved, administering it in 2 divided doses. Dose titration should be determined according to clinical effect. Doses of up to 30mg/kg per day have been used and were generally well tolerated.
This drug is used for the prevention of epilepsy and migraines and may increase the risk of suicidal thoughts or behaviors when taken. Therefore, patients and caregivers should immediately inform healthcare providers if mood changes or abnormal behaviors occur. This drug can cause serious skin reactions, such as Stevens-Johnson syndrome, so if any unusual skin symptoms occur, it should be discontinued immediately. Patients with poor kidney function may experience delayed drug elimination, requiring dosage adjustments, and patients undergoing dialysis should adjust doses according to dialysis conditions. There's a risk of harming the fetus during pregnancy, so women who are pregnant or planning to become pregnant must consult a doctor before taking this medication and should use effective contraception. This medication can cause central nervous system side effects such as drowsiness, dizziness, and blurred vision, so caution is advised when driving or operating machinery. Adequate hydration is important, and due to the risk of kidney stones, it is recommended to drink plenty of water. Weight changes, mood changes, depression, and memory impairment may occur during use, so regular monitoring of the condition is necessary. This medication can interact with other drugs, so be sure to inform healthcare providers of any other medications being taken, especially with antiepileptic drugs, contraceptives, and lithium. Abruptly stopping the medication can worsen seizures, so tapering should be done gradually under a doctor's supervision.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering and should be kept in a cool, dry place below 25 degrees Celsius.
Yellow round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTopiramate 100mg
Tablet · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.

Topiramate 100mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Topiramate 100mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.

Topiramate 100mg
Tablet · Prescription medication
Albozencore Co., Ltd.

Topiramate 100mg
Tablet · Prescription medication
Pamgen Science Co., Ltd.

Topiramate 25mg
Tablet · Prescription medication
Myungjin Pharmaceutical Co., Ltd.

Topiramate 100mg
Tablet · Prescription medication
Hanlin Pharmaceutical Co., Ltd.

Topiramate 100mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.